Wed 25 Nov 2009 | 14:59 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Myriad Genetics Inc

Myriad Genetics Inc (MYGN.O) (Nasdaq)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View MYGN on other exchanges
As of  2:41pm EST
24.03USD
Price Change
+0.35
Percent Change
+1.48%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Gilbert, Walter 77 -- Vice Chairman of the Board
Meldrum, Peter 62 1991 President, Chief Executive Officer, Director
Critchfield, Gregory 57 -- President of Myriad Genetic Laboratories, Inc.
Marsh, Richard 51 2002 Executive Vice President, General Counsel, Secretary
Lanchbury, Jerry 50 -- Executive Vice President - Research
Wilson, Linda 72 1999 Director
Langer, Dennis 57 2004 Director
Phanstiel, S. Louise 50 2009 Director
Best, Lawrence 60 2009 Director
Skolnick, Mark 63 2000 Chief Scientific Officer, Director
Capone, Mark 47 2006 Chief Operating Officer of Myriad Genetic Laboratories, Inc.
Harrison, Robert 43 2008 Chief Information Officer
Evans, James 46 2007 Chief Financial Officer, Treasurer
Henderson, John 65 2005 Chairman of the Board